Axios on MSN2h
Signs of optimism for biopharma at JPM conferenceAfter several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...
Investment analysts at Brookline Capital Management issued their FY2029 earnings estimates for shares of Moderna in a note issued to investors on Monday, January 13th. Brookline Capital Management ...
RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on January 13 and set a price target of $40.00. The ...
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks ...
Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...
Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback